The effects of the 5-HT(1A) agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat

European Neuropsychopharmacology

Volumn 7, Issue 2, 1997, Pages 109-114

  Cryan, J F ^a   Redmond, A M ^a   Kelly, J P ^a   Leonard, B E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

'Open field' activity; 5 HT(1A) receptor; 8 OH DPAT induced hypothermia; Flesinoxan; Forced Swim Test; Olfactory bulbectomy

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTIDEPRESSANT AGENT; FLESINOXAN; SEROTONIN 1A AGONIST; PIPERAZINE DERIVATIVE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG SCREENING; FORCED SWIMMING TEST; HYPOTHERMIA; MALE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS;

EID: 0030610015     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(96)00391-4     Document Type: Article

References (48)

1. 1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur. J. Pharmacol. 200, 259-266.
2. 1A agonist in major depression: Effect on sleep REM latency and body temperature. Hum. Psychopharmacol. 8, 279-283.
3. Barrett, J.E. and Vanover, K. (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacol. 112, 1-12.
4. 1A compound flesinoxan. J. Psychopharmacol. 3, 64-69.
5. Blier, P. and De Montigny, C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
6. Borsini, F. and Meli, A. (1988) Is the forced swim test a suitable model for revealing antidepressant activity? Psychopharmacol. 94, 147-161.
7. Cairncross, K.D, Wren, A.F., Cox, B. and Schieden, H. (1977) Effects of olfactory bulbectomy and domicile on stress induced corticosterone release in the rat. Physiol. Behav. 19, 485-487.
8. 1A receptor agonist. Eur. J. Pharmacol. 144, 223-229.
9. Cervo, L., Grignaschi, G. and Samanin, R. (1988) Different effects of buspirone in the forced swimming test: involvement of a metabolite. Life Sci. 43: 2095-2102.
10. Cesana, R., Ciprandi, C. and Borsini, F. (1995) The effect of BIMT 17, a new potential antidepressant, in the forced swimming test in mice. Behav. Pharmacol. 6, 688-694.
11. 1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. Neuropharmacology, 30, 711-717.
12. 1A Receptors in Depression and Anxiety. Raven Press, New York, pp. 55-81.
13. 1A receptor ligands 8-OH-DPAT and ipsapirone in animal models of anxiety and depression. Drug Develop. Res. 30, 91-103.
14. 1A receptor agonists: recent developments and controversial issues. Psychopharmacol. 121, 1-26.
15. Goodwin, G.M., De Souza, R.J. and Green, A.R. (1985) Presynaptic serotonin receptor response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317, 531-533.
16. 1A receptor-mediatd hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacol. 91, 500-505.
17. Gray, J.A. and Lalljee, B. (1974) Sex differances in emotional behaviour in the rat: correlation between the 'open field' defecation and acute avoidance. Animal Behav. 22, 856-861.
18. 1A receptor agonist, in treatment resistant depression. Int. Clin. Psychopharmacol. 8, 167-172.
19. Handley, S.L. and McBlane, J.W. (1993) 5-HT drugs in animal models of anxiety. Psychopharmacol. 112, 13-20.
20. Janscar, S. and Leonard, B.E. (1984) Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog. Neuropsychopharmacol. Biol. Psychiat. 8, 263-269.
21. Jesberger, J.A. and Richardson, J.S. (1986) Effects of antidepressant drugs on the behavior of olfactory bulbectomised and sham-operated rats. Behav. Neurosci. 100, 256-274.
22. Jesberger, J.A. and Richardson, J.S. (1988) Brain output dysregulation by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans?. Intern. J. Neurosci. 388, 241-265.
23. Kelly, J.P. (1991) The olfactory bulbectomised rat as a model of depression: Biochemical, behavioural and neuroendocrine correlates. Ph.D. Thesis, National University of Ireland.
24. Kelly, J.P. and Leonard, B.E. (1994) The effect of chronic tianeptine and sertraline in three animal models of depression. Neuropharmacol. 33, 1011-1016.
25. Leonard, B.E. and Tuite, M. (1981) Anatomical, physiological and behavioural aspects of olfactory bulbectomy in the rat. Int. Rev. Neurobiol. 22, 251-286.
26. Lucki, I., Singh, A. and Kreiss, D.S. (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18, 85-95.
27. McGrath, C. (1996) The olfactory bulbectomised rat model of depression: Biochemical, Neurochemical and Pharmacological studies. National University of Ireland, Ph.D. Thesis. 163-188.
28. McNamara, M.G., Kelly, J.P. and Leonard, B.E. (1995) Effects of 8-OHDPAT in the olfactory bulbectomised rat model of depression. J. Serotonin Res. 2, 91-99.
29. McNamara, M.G., Kelly, J.P. and Leonard, B.E. (1996) Some behavioural and neurochemical effects of isapirone in two rodent models of depression. J. Psychopharmacol. 10, 126-133.
30. 1A agonists - a comparative review. CNS Drugs 3, 234-251.
31. Porsolt, R.D., Anton, G., Blavet, N. and Jalfre, M. (1978) Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47, 379-391.
32. 1A receptor agonist, flesinoxan. Pharmacol. Biochem. Behav. 48, 959-963.
33. Sanchez, C. (1993) Effect of serotonergic drugs on foot shock-induced ultrasonic vocalisation in adult male rats. Behav. Pharmacol. 4, 269-277.
34. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95, 975-985.
35. Schipper, J., Tulp, M.T.M., Krijzer, F., Mos, J., Van der Heyden, J.A.M. and Olivier, B. (1990) Preclinical evaluation of flesinoxan as a potential anxiolytic and antidepressant drug. Eur. J. Pharmacol. 183, 2059-2060.
36. Schipper, J., Tulp, M.T.M., Berkelmans, B., Mos, J., Van der Heyden, J.A.M. and Olivier, B. (1991) Preclinical pharmacology of flesinoxan: A potential anxiolytic and antidepressant drug. Human Psychopharmacol. 6 (suppl), 53-61.
37. Song, C. and Leonard, B.E. (1995) The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function. Hum. psychopharmacol. 10, 7-18.
38. Sulser, F. Noradrenergic receptor regulation and the action of antidepressants. In: Depression and Antidepressants - Recent Events. Excerpta Medica, Amsterdam, (1983) pp. 24-36.
39. van der Poel, A.M., Molewijk, H.E. Mos, J. and Olivier, B. (1991) In: Olivier, B., Mos, J. and Slangen, J.L., (Eds.) Animal models in psychopharmacology Birkhauser Verlag, Basel, (1991), pp. 107-116.
40. van Hest, A., van Drimmelen, M. and Olivier, B. (1992) Flesinoxan shows antidepressant activity in a DRL 72-s screen. Psychopharmacol. 107, 474-479.
41. van Reizen, H. and Leonard, B.E. (1991) Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats. In: File, S.E.(Ed.), Psychopharmacology of Anxiolytics and Antidepressants, Pergamon Press Inc. (New York), pp. 231-250.
42. Willner, P. (1990) Animal models of depression: an overview. Pharmac. Ther. 45, 425-455.
43. Willner, P. (1995) Animal models of depression: validity and applications. In: Gessa, G., Fratta, W., Pani, L. and Serra, G. (Eds.), Depression and Mania: From Neurobiology to Treatment. Raven Press, New York, pp. 19-41
44. 1A receptors. Eur. J. Pharmacol. 133, 47-56.
45. Wozniak, K.M., Aulakh, C.S., Hill, J.L., and Murphy, D.L. (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol. Biochem. Behav. 30, 451-456.
46. Ybema, C.E, Slangen, J.L., Olivier, B. and Mos, J. (1990) Discriminative stimulus properties of the serotonergic compound flesinoxan. Pharmacol. Biochem. Behav. 35, 781-784.
47. Ybema, C.E, van den Broek, I., Slangen, J.L., Olivier, B. and Mos, J. Further characterisation of the discriminative stimulus induced by flesinoxan. In: Olivier, B., Mos, J. and Slangen, J.L. (Eds.) Animal Models in Psychopharmacology, Birkhauser Verlag, Basel, (1991), pp. 387-395.
48. Zethof, T.J.J., van der Heyden, J.A.M. and Olivier, B. (1991) A new animal model for anticipatory fear? In: Olivier, B., Mos, J. and Slangen, J.L. (Eds.) Animal Models in Psychopharmacology, Birkhauser Verlag, Basel, pp. 65-68.